| 22.05 Data as of Jun 18 | -0.32 / -1.43%Today’s Change | 8.60 Today|||52-Week Range 22.67 | +75.70% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $537.8M |
Company Description
Cardiovascular Systems, Inc. is a medial device company that develops and sells devices for treating cardiovascular diseases. It focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. The company's products such as diamondback 360 ° PAD system and the stealth 360 ° PAD system are catheter based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee. It was formerly known as Replidyne, Inc. The company was founded in 2000 and is headquartered in St. Paul, MN.
Employees

Shareholders
| Other institutional | 33.33% |
| Individual stakeholders | 24.77% |
| Mutual fund holders | 18.68% |
Top Executives
| David L. Martin, MBA | President, Chief Executive Officer & Director |
| Laurence L. Betterley, CPA | Chief Financial Officer |
| James E. Flaherty, CPA | Secretary & Chief Administrative Officer |
| Robert J. Thatcher, MBA | Executive Vice President |
| Paul Koehn, MBA | Vice President-Quality & Operations |